| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



From the Magee-Womens Research Institute and Department of
Obstetrics, Gynecology and Reproductive Sciences,*
University of Pittsburgh, Pittsburgh, Pennsylvania; and the
Departments of Stomatology
and of
Anatomy, Pharmaceutical Chemistry, and Obstetrics, Gynecology and
Reproductive Sciences,
University of
California at San Francisco, San Francisco, California
In preeclampsia, poor placental perfusion may result in maternal endothelial dysfunction, but the pathways involved are largely unknown. Candidate placental mediators include products of oxidative stress released into the maternal circulation. Xanthine oxidase has been implicated in postischemic-reperfusion injury via the generation of superoxide anion radicals (superoxide; O2.-) and hydrogen peroxide. We examined placentas and placental bed curettings and/or biopsies from preeclamptic control pregnant women to test the hypothesis that xanthine oxidase is a mediator of oxidative stress in placentas from women with preeclampsia. The expression of xanthine dehydrogenase/xanthine oxidase holoenzyme and the activity of xanthine oxidase, the isoform known to generate reactive oxygen species, were increased in a subpopulation of cytotrophoblasts of preeclamptic women. Additionally, the expression of superoxide dismutase, which would scavenge superoxide produced by xanthine oxidase, was reduced in the same cells. Furthermore, fluorescence immunostaining for nitrotyrosine, which was suggestive of superoxide-nitric oxide interactions to form peroxynitrite anion (ONOO-) in vivo, was increased in these cells and in villous vessels. Thus, our data indicate an increased capacity of placental cells to generate reactive oxygen species in preeclampsia.
This article has been cited by other articles:
![]() |
I. Craici, S. Wagner, and V. D. Garovic Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 249 - 259. [Abstract] [PDF] |
||||
![]() |
P. Lopez-Jaramillo, W. D. Arenas, R. G. Garcia, M. Y. Rincon, and M. Lopez Review: The role of the L-arginine-nitric oxide pathway in preeclampsia Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 261 - 275. [Abstract] [PDF] |
||||
![]() |
R. E. Gandley, J. Rohland, Y. Zhou, E. Shibata, G. F. Harger, A. Rajakumar, V. E. Kagan, N. Markovic, and C. A. Hubel Increased Myeloperoxidase in the Placenta and Circulation of Women With Preeclampsia Hypertension, August 1, 2008; 52(2): 387 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jauniaux, L. Poston, and G. J. Burton Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution Hum. Reprod. Update, November 1, 2006; 12(6): 747 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nash, M. Olovsson, and U. J. Eriksson Placental Dysfunction in Suramin-Treated Rats: Impact of Maternal Diabetes and Effects of Antioxidative Treatment Reproductive Sciences, April 1, 2005; 12(3): 174 - 184. [Abstract] [PDF] |
||||
![]() |
D. M. Shah Role of the renin-angiotensin system in the pathogenesis of preeclampsia Am J Physiol Renal Physiol, April 1, 2005; 288(4): F614 - F625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerjee, A. Smallwood, J. Moorhead, A. E. Chambers, A. Papageorghiou, S. Campbell, and K. Nicolaides Placental Expression of Interferon-{gamma} (IFN-{gamma}) and Its Receptor IFN-{gamma}R2 Fail to Switch from Early Hypoxic to Late Normotensive Development in Preeclampsia J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 944 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. M. Raijmakers, R. Dechend, and L. Poston Oxidative Stress and Preeclampsia: Rationale for Antioxidant Clinical Trials Hypertension, October 1, 2004; 44(4): 374 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hubel, L. M. Bodnar, A. Many, G. Harger, R. B. Ness, and J. M. Roberts Nonglycosylated Ferritin Predominates in the Circulation of Women with Preeclampsia but Not Intrauterine Growth Restriction Clin. Chem., May 1, 2004; 50(5): 948 - 951. [Full Text] [PDF] |
||||
![]() |
G. K. Kumar and J. B. Klein Analysis of expression and posttranslational modification of proteins during hypoxia J Appl Physiol, March 1, 2004; 96(3): 1178 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Hung, D. S. Charnock-Jones, J. N. Skepper, and G. J. Burton Secretion of Tumor Necrosis Factor-{alpha} from Human Placental Tissues Induced by Hypoxia-Reoxygenation Causes Endothelial Cell Activation in Vitro: A Potential Mediator of the Inflammatory Response in Preeclampsia Am. J. Pathol., March 1, 2004; 164(3): 1049 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noris, M. Todeschini, P. Cassis, F. Pasta, A. Cappellini, S. Bonazzola, D. Macconi, R. Maucci, F. Porrati, A. Benigni, et al. L-Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant Species Hypertension, March 1, 2004; 43(3): 614 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bauer, J. Pollheimer, J. Hartmann, P. Husslein, J. D. Aplin, and M. Knofler Tumor Necrosis Factor-{alpha} Inhibits Trophoblast Migration through Elevation of Plasminogen Activator Inhibitor-1 in First-Trimester Villous Explant Cultures J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 812 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dechend, C. Viedt, D. N. Muller, B. Ugele, R. P. Brandes, G. Wallukat, J.-K. Park, J. Janke, P. Barta, J. Theuer, et al. AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase Circulation, April 1, 2003; 107(12): 1632 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Roberts, G. Pearson, J. Cutler, and M. Lindheimer Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy Hypertension, March 1, 2003; 41(3): 437 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Hung, J. N. Skepper, D. S. Charnock-Jones, and G. J. Burton Hypoxia-Reoxygenation: A Potent Inducer of Apoptotic Changes in the Human Placenta and Possible Etiological Factor in Preeclampsia Circ. Res., June 28, 2002; 90(12): 1274 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Hung, J. N. Skepper, and G. J. Burton In Vitro Ischemia-Reperfusion Injury in Term Human Placenta as a Model for Oxidative Stress in Pathological Pregnancies Am. J. Pathol., September 1, 2001; 159(3): 1031 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Black, H. Yu, J. Lee, M. Sachchithananthan, and R. L. Medcalf Physiologic Concentrations of Magnesium and Placental Apoptosis: Prevention by Antioxidants Obstet. Gynecol., August 1, 2001; 98(2): 319 - 324. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |